Clinical trials
Respiratory Tract Infections clinical trials
Below are recruiting respiratory tract infections clinical trials, each written for real people, not researchers. We’re tracking 87 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07041671Recruiting
Can a mouth spray reduce virus in breath?
This trial tests whether ColdZyme mouth spray can lower the amount of virus you breathe out when you have a cold or flu-like illness. It may help you recover faster and reduce spreading the virus to others.
LundAges 18 years+ - NCT07823231Recruiting
Climate-resilient water and hygiene for schools and clinics in Karamoja
This study tests whether improving access to clean water, sanitation, and hygiene in schools and health facilities helps students and the community stay healthier. If your school is selected, your family may benefit from safer water and better hygiene.
MorotoAges Any age - NCT07787130Recruiting
Testing a supplement for preventing colds
This trial tests whether a daily supplement called Immune X can help prevent colds in healthy adults. If you often get colds and are in good health, you might be able to join.
Dijon, Côte-d'OrAges 18–65 - NCT07578012RecruitingPhase 4
Ismigen to prevent respiratory infections in children
This study tests whether a medicine called Ismigen can help children who get frequent respiratory infections (like colds, bronchitis, or throat infections) stay healthier. The medicine is made from bacterial components designed to strengthen the immune system.
BialystokAges 3–12 - NCT07498127Enrolling by invitationPhase 2
Probiotics for colds in young children
This trial tests whether taking probiotics can help young children recover faster from common colds. If your child has a mild or moderate cold and is not taking other probiotics, they may be able to join.
Xuhui, Shanghai MunicipalityAges 3 months–6 years - NCT05421325RecruitingPhase 2
Vaccine-like immune treatment to prevent lung infections in seniors
This Phase 2 study tests a site-specific immune “booster” in people age 65 and older to help improve natural immunity and reduce respiratory (lung/airway) infections. You may be eligible if you can consent, are in an eligible living situation, and are not currently using certain immune-suppressing medicines.
Burnaby, British ColumbiaAges 65 years+ - NCT07383350Enrolling by invitation
Information sheets for better communication on antibiotics
This study tests if using simple information sheets helps you and your doctor talk better about infections like sore throat, sinusitis, or bronchitis, and make wise decisions about antibiotics — so you only get them when truly needed.
AalborgAges 18 years+ - NCT07149428Recruiting
Deep study of smell loss causes using brain scans
This study uses brain imaging and electrical recordings to understand the brain's role in smell loss from any cause—like COVID, sinus problems, or chemotherapy. You may be eligible if you have any degree of smell loss lasting under a year.
Bethesda, MarylandAges 18–99 - NCT06953804Recruiting
Better use of antibiotics in GP clinics
This study looks at how to improve the use of antibiotics (antimicrobial stewardship) in general practice clinics. It aims to find the best ways to help doctors prescribe antibiotics only when needed.
Wollongong, New South WalesAges 18 years+ - NCT06788093Recruiting
Reducing antibiotic overuse with decision support
This trial tests a tool to help doctors decide when antibiotics are truly needed for lung infections like bronchitis or pneumonia. It may help you avoid unnecessary antibiotics and their side effects.
Oakland, CaliforniaAges 6 months–17 years - NCT06636890Enrolling by invitation
Testing a new method for detecting certain bacteria in lung infections
This study checks if a special test (Xpert Carba-R) can find a type of drug-resistant bacteria, called CRE, in fluid from the lungs and in rectal swabs. It might help doctors treat lower respiratory tract infections more effectively.
Nanjing, JiangsuAges 18–90 - NCT06521892Enrolling by invitation
Improving antibiotic sales in Hubei pharmacies
This study tests ways to improve how community pharmacies in Hubei Province handle antibiotic sales without a prescription. It aims to find better practices to prevent misuse.
Wuhan, HubeiAges Any age - NCT06070688Recruiting
A test to tell if your breathing infection is bacterial or viral
This study tests a new way to quickly figure out if a respiratory infection is caused by bacteria or a virus. Knowing this could help doctors choose the right treatment faster and avoid unnecessary antibiotics.
Houston, TexasAges 18 years+ - NCT05063149RecruitingPhase 3
Bacterial lysate for preventing breathing infections in preterm infants
This study tests a medicine called a bacterial lysate, which might help prevent respiratory infections and wheezing in babies born early. It could reduce sickness and breathing problems in the first year of life.
Rotterdam, South HollandAges 1 month–2 months - NCT07420985RecruitingPhase 2
Ingavirin forte for flu and other viral infections
This trial tests different doses of Ingavirin Forte capsules for treating influenza and other respiratory viruses. It may help people with fever, cough, sore throat, and body aches who have been sick less than 48 hours.
IvanovoAges 18–65 - NCT06998264Recruiting
Immune response to flu in young children
This study looks at how children's immune systems fight the flu in the nose and throat. It aims to understand why some children get very sick and others don't, which could help create better treatments and vaccines.
GenevaAges 2–5 - NCT07283497RecruitingPhase 4
Itraconazole for bronchiectasis with airway mold growth
This Mayo Clinic study tests whether the oral antifungal drug itraconazole can help people with bronchiectasis who have mold growing in their airways. The goal is to see if it improves symptoms and reduces mold in the lungs.
Rochester, MinnesotaAges 18 years+ - NCT07359287Recruiting
Study on antibiotic use for respiratory infections
This study tests a program to help doctors prescribe antibiotics more carefully for common respiratory infections like colds, flu, bronchitis, and sinusitis. It may lead to better treatment for you.
CaenAges Any age - NCT07322146Enrolling by invitationPhase 4
Shorter antibiotics for children with common infections
This study tests whether shorter courses of antibiotics are as effective as longer ones for children hospitalized with pneumonia, skin infections, or urinary tract infections. It may help children get back to normal faster and reduce side effects.
Birmingham, AlabamaAges 2 months–17 years - NCT07860216RecruitingPhase 3
RSV vaccine safety and immune response study for older adults
This trial tests an experimental vaccine to protect older adults against respiratory syncytial virus (RSV), a common virus that can cause serious lung infections. It looks at whether the vaccine is safe and how well it boosts immunity. If you are healthy and over 60, you might be able to join.
GuiZhou, GuizhouAges 60 years+ - NCT06690203Enrolling by invitation
Herbal Medicine for Chronic Lung Conditions (NRICM102)
This trial tests an herbal medicine called NRICM102 for people with chronic cough and long-term lung diseases like asthma or COPD. It aims to see if the medicine is safe and helps improve symptoms.
Taichung, No.1650, Taiwan Boulevard Sect. 4Ages 18 years+ - NCT06197152Recruiting
RSV severity markers in hospitalized adults
This study looks for markers in the blood that can tell how serious an RSV infection might become. If you are hospitalized with RSV and have breathing symptoms, this trial will follow your recovery and test for clues about your illness.
CréteilAges 18 years+ - NCT07000877RecruitingPhase 4
Nasal spray to help kids with colds during anesthesia
This study tests whether a nasal decongestant spray can help prevent breathing problems during anesthesia for children with a cold. If your child has a recent cold and is having surgery, this could help make the anesthesia safer.
Perth, WeAges 1–8 - NCT05336851Recruiting
Emergency breathing test study for sudden lung infections
This trial tests an emergency breathing-related approach for adults with a sudden, community-acquired respiratory infection. It may help doctors quickly sort out what’s going on and guide early care.
Hong KongAges 18–100
Hear when a new Respiratory Tract Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for respiratory tract infections?
- Yes. Clin2 currently lists 87 recruiting respiratory tract infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a respiratory tract infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a respiratory tract infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.